Merck Is Partnering With America’s Largest HBCU To Launch a Collaborative Biotechnology Learning Center
Merck has partnered with North Carolina Agricultural and Technical State University (N.C. A&T), the largest historically Black college and university in the U.S., to launch the Merck Biotechnology Learning Center. The 4,025 square-foot facility, located near Merck's Durham and Wilson manufacturing sites, will enhance academic programming and training for biotechnology careers. This collaboration aims to diversify talent, expand local bioeconomy initiatives, and provide advanced discovery opportunities. It also includes training in vaccine manufacturing processes for new and existing employees.
- Merck's collaboration with N.C. A&T aligns with company priorities on diversity and innovation.
- The 4,025 square-foot facility will enhance biotechnology career training.
- The initiative aims to diversify talent and expand bioeconomy initiatives locally and statewide.
- The center offers advanced discovery opportunities and practical training in biopharmaceutical manufacturing.
- New and existing employees will receive vaccine manufacturing process training.
- None.
NORTHAMPTON, MA / ACCESSWIRE / June 20, 2024 / Building the workforce of tomorrow means investing in the students of today. That's why Merck has partnered with North Carolina Agricultural and Technical State University (N.C. A&T) - the largest historically Black college and university in the U.S. - to launch the Merck Biotechnology Learning Center.
"We're pleased to launch this new collaboration with an institution that precisely aligns to our company priorities to invest in the growth and delivery of innovative health solutions and strong values around diversity and inclusion," said Sanat Chattopadhyay, executive vice president and president, Merck Manufacturing Division. "Together we can fuel the growth of talent for our company and the biotechnology industry overall."
Located in the home state of the company's Durham and Wilson manufacturing sites, the 4,025 square-foot facility will enhance academic programming and training for biotechnology careers for N.C. A&T students and provide advanced discovery opportunities through its classroom space, process laboratory and state-of-the-art biopharmaceutical manufacturing equipment.
"This collaboration signifies a union between academia and industry, and a commitment to excellence, innovation and the advancement of scientific knowledge," said Tonya Smith-Jackson, Ph.D., provost and executive vice chancellor of academic affairs for N.C. A&T.
The collaboration also signifies an investment in the community's future by expanding local and statewide bioeconomy initiatives. Additionally, it will help to diversify talent and recruitment opportunities for Merck and offer vaccine manufacturing process training for new and existing employees.
"The Merck Biotechnology Learning Center will provide opportunities for N.C. A&T students to look inside the biopharmaceutical industry and understand what a career in this space looks like. Through our joint initiative with N.C. A&T, we're developing new and innovative ways to build a pipeline of talent here in North Carolina and beyond," added Amanda Taylor, vice president and Durham plant manager, Merck.
View original content here.
View additional multimedia and more ESG storytelling from Merck & Co., Inc. on 3blmedia.com.
Contact Info:
Spokesperson: Merck & Co., Inc.
Website: https://www.3blmedia.com/profiles/merck-co-inc
Email: info@3blmedia.com
SOURCE: Merck & Co., Inc.
View the original press release on accesswire.com
FAQ
What is Merck's new collaboration about?
When was the Merck Biotechnology Learning Center announced?
Where is the Merck Biotechnology Learning Center located?
How large is the Merck Biotechnology Learning Center?
What opportunities will the Merck Biotechnology Learning Center provide?
